| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/19/2000 | EP1019391A1 Inhibitors of prenyl-protein transferase |
| 07/19/2000 | EP1019383A2 Process for the aminocarbonylation of benzazepines and benzodiazepines |
| 07/19/2000 | EP1019382A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| 07/19/2000 | EP1019379A1 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein |
| 07/19/2000 | EP1019377A1 Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 (nk-3)- and neurokinin 2 (nk-2) receptor antagonists. |
| 07/19/2000 | EP1019373A1 Novel human nk 3? receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 07/19/2000 | EP1019372A1 Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019054A1 Treatment of skin disorders |
| 07/19/2000 | EP1019053A1 Amorphous paroxetine composition |
| 07/19/2000 | EP1019052A1 Alpha 1a adrenergic receptor antagonists |
| 07/19/2000 | EP1019051A1 Peripherally acting anti-pruritic opiates |
| 07/19/2000 | EP1019050A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 07/19/2000 | EP1019046A1 Protease inhibitors |
| 07/19/2000 | EP1019045A1 Antithrombotic agents |
| 07/19/2000 | EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
| 07/19/2000 | EP1018879A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 07/19/2000 | EP0821682B1 Benzimidazole compounds and their use as modulators of the gaba-a receptor complex |
| 07/19/2000 | EP0735877B1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists |
| 07/19/2000 | EP0664291B1 Pyrimidine compound |
| 07/19/2000 | EP0482208B1 Pyridazinone derivative |
| 07/19/2000 | CN1260793A 4-haloalkyl-3-heterocyclyl pyridines and 4-haloalkyl-5-heterocyclylpyridines, method for producing same, composition containing same and use thereof |
| 07/19/2000 | CN1260791A 3-benzylpiperidine |
| 07/19/2000 | CN1260781A Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagoinist activity |
| 07/19/2000 | CN1260345A Hydrazide compound, its preparing method and medicine compositions thereof |
| 07/19/2000 | CN1054594C Inhibition of unsaturated monomers with 7-aryl quinone methides |
| 07/18/2000 | US6090947 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 07/18/2000 | US6090927 Cyanobutanone and succinonitrile substituted with ap-chlorophenylsulfonyl- and a 4-(trifluoromethyl)-2,6-dichlorophenylazo group |
| 07/18/2000 | US6090828 5-aryleheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders |
| 07/18/2000 | US6090826 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 07/18/2000 | US6090824 Therapeutic neurokinin receptor antagonist compounds |
| 07/18/2000 | US6090818 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
| 07/18/2000 | US6090813 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 07/18/2000 | US6090812 Therapy for psychological, central nervous system disorders |
| 07/18/2000 | US6090810 Side effect reduction |
| 07/18/2000 | US6090809 1-(4-arylpiperazin-1-yl)-ω-[n-(α..omega.-dicarboximido)]-alkanes useful as uro-selective α1 -adrenoceptor blockers |
| 07/18/2000 | US6090808 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
| 07/18/2000 | CA2017376C Diarylstyrylquinoline diacids |
| 07/18/2000 | CA2003289C Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders |
| 07/13/2000 | WO2000040582A1 Cyclic guanidine derivatives and their use as pesticides |
| 07/13/2000 | WO2000040578A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 07/13/2000 | WO2000040565A1 Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors |
| 07/13/2000 | WO2000040562A1 2-oxoquinoline compounds and medicinal uses thereof |
| 07/13/2000 | WO2000040561A1 Quinolinecarboxamides as antiviral agents |
| 07/13/2000 | WO2000040554A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 07/13/2000 | WO2000040243A1 Novel compounds |
| 07/13/2000 | WO2000040087A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors |
| 07/13/2000 | WO2000021927A3 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 07/13/2000 | DE19900544A1 Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie Use of compounds of formula I for the prophylaxis and therapy of cerebral ischemia |
| 07/13/2000 | DE19900519A1 Substituierte Guanidin-Derivate Substituted guanidine derivatives |
| 07/13/2000 | DE19900355A1 New 2-(naphthalen-2-ylmethyl)-benzimidazole derivatives are Factor VIIa, IXa, Xa and thrombin inhibitors useful for treating thrombosis and other cardiovascular disorders, inflammation and apoplexy |
| 07/13/2000 | CA2358939A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 07/13/2000 | CA2358879A1 2-oxoquinoline compounds and pharmaceutical uses thereof |
| 07/13/2000 | CA2358586A1 Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors |
| 07/13/2000 | CA2358576A1 Cyclic guanidine derivatives and their use as pesticides |
| 07/13/2000 | CA2358241A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors |
| 07/13/2000 | CA2355342A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 07/13/2000 | CA2353636A1 Quinolinecarboxamides as antiviral agents |
| 07/12/2000 | EP1018513A2 Quinolinecarboxylic acid derivatives |
| 07/12/2000 | EP1018008A2 Method of identification of leads or active compounds |
| 07/12/2000 | EP1017692A1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 07/12/2000 | EP1017691A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 07/12/2000 | EP1017682A1 Novel angiogenesis inhibitors |
| 07/12/2000 | EP1017680A1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 07/12/2000 | EP1017677A1 4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein |
| 07/12/2000 | EP1017673A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
| 07/12/2000 | EP1017395A1 Method for treating premenstrual or late luteal phase syndrome |
| 07/12/2000 | EP1017393A1 Pyrazinone thrombin inhibitors |
| 07/12/2000 | EP1017387A1 Vitronectin receptor antagonist |
| 07/12/2000 | EP1017386A1 GRANULAR PREPARATIONS OF 5-(2-ETHYL- 2$i(H)-TETRAZOL- 5-YL)-1-METHYL-1, 2,3,6-TETRAHYDROPYRIDINE |
| 07/12/2000 | EP1017385A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/12/2000 | EP0877734B1 Quinoline and quinazoline compounds useful in therapy |
| 07/12/2000 | EP0792289B1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 07/12/2000 | EP0788486B1 Herbicidal sulfonyl urea derivatives |
| 07/12/2000 | EP0719772B1 Optically active imidazolidinone derivative and process for producing the same |
| 07/12/2000 | EP0561850B1 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds useful as antibacterial agents |
| 07/12/2000 | CN1259943A Substituted aryluracils |
| 07/12/2000 | CN1259942A Novel guanidine mimics as factor Xa inhibitors |
| 07/12/2000 | CN1259935A Substituted naphthopyrans |
| 07/12/2000 | CN1259868A Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for treating cancer |
| 07/12/2000 | CN1259346A Optically pure compound as medicinal use |
| 07/12/2000 | CN1054374C New (thia) cycloalkyl [b] indole compounds process for the prepn. thereof and pharmaceutical compositions containing them |
| 07/11/2000 | US6087496 Enzyme inhibitors |
| 07/11/2000 | US6087387 3-acetyl-1-phenyl-pyrazole derivatives insecticide useful in the control of insects, nematodes or helminths |
| 07/11/2000 | US6087381 Pyrazole derivatives as p38 kinase inhibitors |
| 07/11/2000 | US6087380 Antithrombotic benzimidazoles; anticoagulants; 2-(n-(4-amidinophenyl)-aminomethyl)-benzimidazol-5-yl-carboxylic acids |
| 07/11/2000 | US6087365 Treating drug-resistant malaria in a mammal |
| 07/11/2000 | US6087364 Dopamine D4 receptor antagonists |
| 07/11/2000 | US6087357 Piperazine derivatives as tachykinin antagonists |
| 07/11/2000 | US6086637 Trifluormethylpyridone based indolenine methine dyes |
| 07/11/2000 | CA2208569C Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 07/11/2000 | CA2023340C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
| 07/06/2000 | WO2000039125A1 Piperidines as ccr5 modulators |
| 07/06/2000 | WO2000039119A1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2000 | WO2000039118A1 Aromatic amides |
| 07/06/2000 | WO2000039117A1 HETEROROAROMATIC AMIDES AS INHIBITOR OF FACTOR Xa |
| 07/06/2000 | WO2000039116A1 Aminopyrazole derivatives |
| 07/06/2000 | WO2000039115A1 Protease inhibitors |
| 07/06/2000 | WO2000039114A2 Substituted oximes and hydrazones as neurokinin antagonists |